Esomeprazole based triple therapy regimens (EAC/EAM) on H.pylori eradication therapy showed high success rate even if on EM of CYP2C19 polymorphism or CAM resistance.

Takuji Yamasaki    

UEG Week 2016

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing